130 related articles for article (PubMed ID: 37769965)
1. The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms.
d'Izarny-Gargas T; Isnard P; Boudhabhay I; Buob D; Moktefi A; Linster C; Hummel A; Esteve E; Audard V; Lazareth H; Maroun N; Hertig A; Gosset C; Jouzel C; Permal S; Domenger C; Kosmider O; Rabant M; Karras A; Duong Van Huyen JP
Kidney Int; 2023 Dec; 104(6):1206-1218. PubMed ID: 37769965
[TBL] [Abstract][Full Text] [Related]
2. Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms.
Büttner-Herold M; Sticht C; Wiech T; Porubsky S
Histopathology; 2021 Apr; 78(5):738-748. PubMed ID: 33078472
[TBL] [Abstract][Full Text] [Related]
3. [Myeloproliferative neoplasms related glomerulopathy].
Paule R; Ponsoye M; Gueutin V; Deray G; Izzedine H
Rev Med Interne; 2013 Jun; 34(6):369-72. PubMed ID: 23357690
[TBL] [Abstract][Full Text] [Related]
4. Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms.
Person F; Meyer SC; Hopfer H; Menter T
Virchows Arch; 2021 Nov; 479(5):1013-1020. PubMed ID: 34164707
[TBL] [Abstract][Full Text] [Related]
5. Primary myelofibrosis associated glomerulopathy: significant improvement after therapy with ruxolitinib.
Rajasekaran A; Ngo TT; Abdelrahim M; Glass W; Podoll A; Verstovsek S; Abudayyeh A
BMC Nephrol; 2015 Aug; 16():121. PubMed ID: 26232031
[TBL] [Abstract][Full Text] [Related]
6. Chronic kidney disease in patients with the Philadelphia-negative chronic myeloproliferative neoplasms.
Christensen AS; Møller JB; Hasselbalch HC
Leuk Res; 2014 Apr; 38(4):490-5. PubMed ID: 24630365
[TBL] [Abstract][Full Text] [Related]
7. Serum Uric Acid Levels and Nephrosclerosis in a Population-Based Autopsy Study: The Hisayama Study.
Maki K; Hata J; Sakata S; Oishi E; Furuta Y; Nakano T; Oda Y; Kitazono T; Ninomiya T
Am J Nephrol; 2022; 53(1):69-77. PubMed ID: 35104828
[TBL] [Abstract][Full Text] [Related]
8. Novel Detection of CALR-Mutated Cells in Myeloproliferative Neoplasm-Related Glomerulopathy With Interstitial Extramedullary Hematopoiesis: A Case Report.
Maruyama K; Nakagawa N; Suzuki A; Kabara M; Matsuki M; Shindo M; Iwasaki S; Ogawa Y; Hasebe N
Am J Kidney Dis; 2019 Dec; 74(6):844-848. PubMed ID: 31377025
[TBL] [Abstract][Full Text] [Related]
9. Myeloproliferative neoplasms cause glomerulopathy.
Said SM; Leung N; Sethi S; Cornell LD; Fidler ME; Grande JP; Herrmann S; Tefferi A; D'Agati VD; Nasr SH
Kidney Int; 2011 Oct; 80(7):753-9. PubMed ID: 21654720
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological predictors for progression of chronic kidney disease in nephrosclerosis: a biopsy-based cohort study.
Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Shimizu M; Furuichi K; Wada T
Nephrol Dial Transplant; 2019 Jul; 34(7):1182-1188. PubMed ID: 29788462
[TBL] [Abstract][Full Text] [Related]
11. Age-Based Versus Young-Adult Thresholds for Nephrosclerosis on Kidney Biopsy and Prognostic Implications for CKD.
Asghar MS; Denic A; Mullan AF; Moustafa A; Barisoni L; Alexander MP; Stegall MD; Augustine J; Leibovich BC; Thompson RH; Rule AD
J Am Soc Nephrol; 2023 Aug; 34(8):1421-1432. PubMed ID: 37254246
[TBL] [Abstract][Full Text] [Related]
12. Larger Nephron Size and Nephrosclerosis Predict Progressive CKD and Mortality after Radical Nephrectomy for Tumor and Independent of Kidney Function.
Denic A; Elsherbiny H; Mullan AF; Leibovich BC; Thompson RH; Ricaurte Archila L; Narasimhan R; Kremers WK; Alexander MP; Lieske JC; Lerman LO; Rule AD
J Am Soc Nephrol; 2020 Nov; 31(11):2642-2652. PubMed ID: 32938650
[TBL] [Abstract][Full Text] [Related]
13. Myeloproliferative Neoplasm and Myelodysplastic Syndrome-Associated Renal Disease: A Histopathological Report of Two Cases.
Popov H; Koleva T; Stoyanov GS; Ghenev P
Cureus; 2022 Dec; 14(12):e32388. PubMed ID: 36632253
[TBL] [Abstract][Full Text] [Related]
14. Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry.
Gecht J; Tsoukakis I; Kricheldorf K; Stegelmann F; Klausmann M; Griesshammer M; Schulz H; Hollburg W; Göthert JR; Sockel K; Heidel FH; Gattermann N; Maintz C; Al-Ali HK; Platzbecker U; Hansen R; Hänel M; Parmentier S; Bommer M; Pahl HL; Lang F; Kirschner M; Isfort S; Brümmendorf TH; Döhner K; Koschmieder S
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439237
[TBL] [Abstract][Full Text] [Related]
15. Autopsy study examining non-chronic kidney disease versus chronic kidney disease caused by hypertensive-nephrosclerosis in elderly subjects.
Yamaguchi Y; Takei T; Matsuda Y; Yumura W; Itabashi M; Arai T; Shimizu A
Clin Exp Nephrol; 2022 Jun; 26(6):530-539. PubMed ID: 35118548
[TBL] [Abstract][Full Text] [Related]
16. Modification of the impact of hypertension on proteinuria by renal arteriolar hyalinosis in nonnephrotic chronic kidney disease.
Zamami R; Kohagura K; Miyagi T; Kinjyo T; Shiota K; Ohya Y
J Hypertens; 2016 Nov; 34(11):2274-9. PubMed ID: 27607459
[TBL] [Abstract][Full Text] [Related]
17. Histopathological Association between Vascular Hypertensive Changes and Different Types of Glomerulopathies.
Baki AH; Soliman Y; Seif EI
Arab J Nephrol Transplant; 2014 Jan; 7(1):21-6. PubMed ID: 24702530
[TBL] [Abstract][Full Text] [Related]
18. Histopathology of renal failure after heart transplantation: a diverse spectrum.
Pinney SP; Balakrishnan R; Dikman S; Nair A; Hammond K; Domanski M; Anyanwu AC; Deboccardo G
J Heart Lung Transplant; 2012 Mar; 31(3):233-7. PubMed ID: 21945725
[TBL] [Abstract][Full Text] [Related]
19. Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden.
Landgren O; Goldin LR; Kristinsson SY; Helgadottir EA; Samuelsson J; Björkholm M
Blood; 2008 Sep; 112(6):2199-204. PubMed ID: 18451307
[TBL] [Abstract][Full Text] [Related]
20. Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis.
Momoki K; Kataoka H; Moriyama T; Mochizuki T; Nitta K
J Atheroscler Thromb; 2017 Jun; 24(6):630-642. PubMed ID: 27784849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
